Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KC.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
HK.3.10ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
FY.5.5.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
JC.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-11458.2China
B.1.1.74ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-11458.2China
XBB.2.7.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-11450.7US
BA.4.6.5ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-11447Japan
B.1.564.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-11447Japan
A.28ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11413.6China
GK.2.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11413.6China
BQ.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-11408.3South Korea
FL.39NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-11405.7Thailand
CR.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-11405.7Thailand
BN.1.3.5ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-11395.4Japan
KF.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-11379.2Japan
B.1.625ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-11359.1Japan
BQ.1.3SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-11333.2Japan
B.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-11307.3China
B.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-11298.7Germany
BA.2.33ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-11294.7Japan
B.1.633SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-11231Japan
BA.1.1.16NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-11224.7Germany
AY.5.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-11215.5China
B.50ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-11176.7Hong Kong
B.1.428.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-11160.6China
B.1.1.291ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11076.1China
BA.4.1.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-11063.7Germany
BY.1.2.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11062.8China
B.1.1.426ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-11023.2China
AY.62 (Delta)ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-11023.2China
BA.1.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-10929.3Germany
BF.7.4.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-10921.5Thailand
B.1.36.36ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-10849.5Japan
BF.25ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.5.9ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BF.7.4.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
ED.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.5.2.19ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.2.3.18ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
XATORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.2.65ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.5.1.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BG.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BF.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.2.74ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.5.2.28ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.5.2.62ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BA.2.13.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
BE.1.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
XAZORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10838.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used